Stay updated on Sitravatinib in Hepatic Impairment Clinical Trial
Sign up to get notified when there's something new on the Sitravatinib in Hepatic Impairment Clinical Trial page.

Latest updates to the Sitravatinib in Hepatic Impairment Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe 403 Forbidden page content and the Home link were removed, returning the study detail page to its normal layout. This reflects a transition away from an error state to the standard page presentation.SummaryDifference0.5%

- Check16 days agoChange DetectedThe page now renders a 403 Forbidden error, replacing the study record content with an access-restricted page. As a result, users cannot view the trial's details, investigators, locations, or related information on this page.SummaryDifference18%

- Check37 days agoChange DetectedThe page’s revision label was updated from v3.6.5 to v3.6.6. This signals a minor maintenance update to the page.SummaryDifference0.1%

- Check58 days agoChange DetectedThe page revision was updated from v3.6.4 to v3.6.5, indicating a new version of the page. There is no indication of substantive changes to the study details or content beyond the revision tag.SummaryDifference0.1%

- Check72 days agoChange DetectedThe page now shows a revision label updated from v3.6.3 to v3.6.4. This indicates a site-level update without changes to the study content displayed.SummaryDifference0.1%

- Check94 days agoChange DetectedRevision: v3.6.3 is now shown on the page. The older Revision: v3.6.2 label has been removed.SummaryDifference0.1%

Stay in the know with updates to Sitravatinib in Hepatic Impairment Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sitravatinib in Hepatic Impairment Clinical Trial page.